Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U W Tunn

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
BJU International|November 4, 2004
Assessment and management of high-risk patientsU W Tunn
Progress in Clinical and Biological Research|January 1, 1989
Cyproterone acetate in the management of prostatic cancerU W Tunn
European Urology|January 1, 1996
Intermittent endocrine therapy of prostate cancerU W Tunn
BJU International|November 4, 2004
Advanced prostate cancer treatment guidelines: European perspectiveU W Tunn
Urological Research|January 1, 1997
Neo-adjuvant hormonal therapy of prostate cancerU W Tunn
Archives of Internal Medicine|October 25, 1982
Sepsis associated with urinary tract infection. Antibiotic treatment with piperacillinU W Tunn, H Thieme
Prostate Cancer and Prostatic Diseases|November 26, 2008
Safety and clinical efficacy of a new 6-month depot formulation of leuprorelin acetate in patients with prostate cancer in EuropeU W Tunn, K Wiedey
Steroids|July 1, 1987
Effects of the aromatase inhibitor testolactone on human benign prostatic hyperplasiaH U Schweikert, U W Tunn
European Urology|October 12, 2000
Intermittent androgen blockade in prostate cancer: rationale and clinical experienceJ M Wolff, U W Tunn
Journal D'Urologie|January 1, 1993
[Aromatase inhibitors in the medical treatment of benign prostatic hypertrophy]U W Tunn, A J Goldschmidt
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
BJU International|November 4, 2004
Assessment and management of high-risk patientsU W Tunn
Progress in Clinical and Biological Research|January 1, 1989
Cyproterone acetate in the management of prostatic cancerU W Tunn
European Urology|January 1, 1996
Intermittent endocrine therapy of prostate cancerU W Tunn
BJU International|November 4, 2004
Advanced prostate cancer treatment guidelines: European perspectiveU W Tunn
Urological Research|January 1, 1997
Neo-adjuvant hormonal therapy of prostate cancerU W Tunn
Archives of Internal Medicine|October 25, 1982
Sepsis associated with urinary tract infection. Antibiotic treatment with piperacillinU W Tunn, H Thieme
Prostate Cancer and Prostatic Diseases|November 26, 2008
Safety and clinical efficacy of a new 6-month depot formulation of leuprorelin acetate in patients with prostate cancer in EuropeU W Tunn, K Wiedey
Steroids|July 1, 1987
Effects of the aromatase inhibitor testolactone on human benign prostatic hyperplasiaH U Schweikert, U W Tunn
European Urology|October 12, 2000
Intermittent androgen blockade in prostate cancer: rationale and clinical experienceJ M Wolff, U W Tunn
Journal D'Urologie|January 1, 1993
[Aromatase inhibitors in the medical treatment of benign prostatic hypertrophy]U W Tunn, A J Goldschmidt
Pageof 4